ANAB · ISSUER CIK 1370053
ANAPTYSBIO, INC
Between Aug 1, 2026 and Oct 29, 2026, 2 ANAPTYSBIO, INC insiders reported $0.00 of open-market purchases and $249K of sales on SEC Form 4.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 1 of 1 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$249KInsider selling
−$249KNet open-market
Oct 2, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 202617:47 | Oct 1, 2026 | ANAB | Director | S · Sell10b5-1 | $49.87 | −5,000 | 10,995 | -31% | −$249K | ||
| Oct 2, 202617:47 | Oct 1, 2026 | ANAB | Director | M · Exercise10b5-1 | $18.03 | +5,000 | 15,995 | +45% | $90K | ||
| Sep 17, 202616:05 | Sep 15, 2026 | ANAB | Director | M · Exercise | — | +1,300 | 17,995 | +8% | — |